200,000+ products from a single source!

sales@angenechem.com

Home > Other Building Blocks > 2879-14-3

2879-14-3

2879-14-3 | 1H-Purine-2,6-dione, 3,9-dihydro-8-phenyl-

CAS No: 2879-14-3 Catalog No: AG002WGV MDL No:

Product Description

Catalog Number:
AG002WGV
Chemical Name:
1H-Purine-2,6-dione, 3,9-dihydro-8-phenyl-
CAS Number:
2879-14-3
Molecular Formula:
C11H8N4O2
Molecular Weight:
228.2068
IUPAC Name:
8-phenyl-3,7-dihydropurine-2,6-dione
InChI:
InChI=1S/C11H8N4O2/c16-10-7-9(14-11(17)15-10)13-8(12-7)6-4-2-1-3-5-6/h1-5H,(H3,12,13,14,15,16,17)
InChI Key:
ACCCXSZCOGNLFL-UHFFFAOYSA-N
SMILES:
O=c1[nH]c2[nH]c(nc2c(=O)[nH]1)c1ccccc1
UNII:
0S2BVG6C31

Properties

Complexity:
340  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
228.065g/mol
Formal Charge:
0
Heavy Atom Count:
17  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0
Molecular Weight:
228.211g/mol
Monoisotopic Mass:
228.065g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
86.9A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0.9  

Literature

Title Journal
Design, synthesis and inhibitory activities of 8-(substituted styrol-formamido)phenyl-xanthine derivatives on monoamine oxidase B. Chemical & pharmaceutical bulletin 20120101
Synthesis of a new series of 1H-imidazol-1-yl substituted 8-phenylxanthines as adenosine receptor ligands. Chemistry & biodiversity 20110701
Progress in the discovery of selective, high affinity A(2B) adenosine receptor antagonists as clinical candidates. Purinergic signalling 20090301
Novel selective antagonist radioligands for the pharmacological study of A(2B) adenosine receptors. Purinergic signalling 20061101
1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists. Journal of medicinal chemistry 20020328
Synthesis of paraxanthine analogs (1,7-disubstituted xanthines) and other xanthines unsubstituted at the 3-position: structure-activity relationships at adenosine receptors. Journal of medicinal chemistry 19931029

Related Products

© 2019 Angene International Limited. All rights Reserved.